REG - Morgan Stanley&CoLLC - Rule 38.5 - ABBVIE INC.

Morgan StanleyAnnouncement

03/04/2020 10:55

RNS Number : 7377I
  
Morgan Stanley & Co. LLC
  
03 April 2020
  
 

 
 FORM 38.5 
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2007 (AS AMENDED)
 
DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS
 
1.             KEY INFORMATION



 Name of exempt market-maker


   Morgan Stanley & Co. LLC




 Company dealt in


   ABBVIE INC.




 Class of relevant security to which the dealings being disclosed relate (Note 1)


  US$0.01 COMMON STOCK




 Date of dealing


   02 APRIL 2020



 
 
2.             DEALINGS (Note 2)
 
(a)           Purchases and sales



 Total number of relevant secuities accquired


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  1,603,232


 75.5000 USD


 71.4500 USD



 



 Total number of relevant secuities disposed


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  1,919,117


 75.5000 USD


 71.4500 USD



 
 
(b)           Derivatives transactions (other than options transactions)
 



 Product name, e.g. CFD


 Nature of transaction 
                (Note 4)


 Number of relevant securities 
                (Note 5)


 Price per unit




 N/A


 N/A


 N/A


 N/A 



 
 
(c)            Options transactions in respect of existing relevant securities
 
i)           Writing, selling, purchasing or varying
 



 Product name, eg call option


 Writing, selling, purchasing, varying etc


 Number of securities to which the option relates (Note 5)


 Exercise Price


 Type, e.g American, European etc 


 Expiry Date 


 Option money paid/received per unit (Note 3)




 PUT


 PURCHASE


 100


 65.0000


A


 03/04/2020


 0.2200 USD




 CALL


 PURCHASE


 100


 80.0000


A


 03/04/2020


 0.0200 USD




 CALL


 PURCHASE


 100


 78.0000


A


 03/04/2020


 0.0900 USD




 CALL


 PURCHASE


 100


 78.0000


A


 03/04/2020


 0.1100 USD




 CALL


 PURCHASE


 300


 75.0000


A


 03/04/2020


 0.6300 USD




 CALL


 PURCHASE


 100


 80.0000


A


 17/04/2020


 0.6600 USD




 CALL


 PURCHASE


 100


 74.0000


A


 03/04/2020


 0.6600 USD




 CALL


 PURCHASE


 1,400


 100.0000


A


 18/09/2020


 0.7000 USD




 CALL


 PURCHASE


 100


 79.0000


A


 17/04/2020


 0.8500 USD




 CALL


 PURCHASE


 200


 80.0000


A


 15/05/2020


 2.0700 USD




 CALL


 PURCHASE


 100


 75.0000


A


 17/04/2020


 2.2300 USD




 CALL


 PURCHASE


 100


 87.5000


A


 21/08/2020


 2.2700 USD




 CALL


 PURCHASE


 100


 87.5000


A


 21/08/2020


 2.2700 USD




 CALL


 PURCHASE


 100


 80.0000


A


 19/06/2020


 3.2700 USD




 CALL


 PURCHASE


 200


 75.0000


A


 15/05/2020


 4.2600 USD




 PUT


 PURCHASE


 100


 80.0000


A


 03/04/2020


 5.3900 USD




 CALL


 PURCHASE


 4,000


 70.0000


A


 15/01/2021


 9.9700 USD




 CALL


 SALE


 100


 77.0000


A


 09/04/2020


 0.8700 USD




 CALL


 SALE


 600


 105.0000


A


 15/01/2021


 0.8800 USD




 PUT


 SALE


 100


 65.0000


A


 15/05/2020


 2.5300 USD




 PUT


 SALE


 100


 50.0000


A


 15/01/2021


 3.2700 USD




 PUT


 SALE


 200


 80.0000


A


 20/11/2020


 14.6800 USD



 
(ii) Exercising
 



 Product name, eg call option


 Number of securities


 Exercise price per unit (Note 3)




 PUT


 200


 92.5000  USD



 
 
3. OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 



Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
 




 
 
 
 
 



 
 



 Date of disclosure


 03 APRIL 2020




 Contact Name


Craig Horsley




 Telephone Number


+44(141) 245 7736 




 Name of offeree/offeror with which connected


ABBVIE INC. 




Nature of connection (Note 6)


Advisory 



 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
ISESSUSADESSELL